Serum cholesterol and treatment-resistance in schizophrenia. - Suppr | 超能文献

Serum cholesterol and treatment-resistance in schizophrenia.

作者信息

Boston P F, Dursun S M, Zafar R, Reveley M A

机构信息

Department of Psychiatry, Faculty of Medicine, University of Leicester, United Kingdom.

出版信息

Biol Psychiatry. 1996 Sep 15;40(6):542-3. doi: 10.1016/0006-3223(96)00102-3.

DOI:10.1016/0006-3223(96)00102-3

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Serum cholesterol and treatment-resistance in schizophrenia.

Biol Psychiatry. 1996 Sep 15;40(6):542-3. doi: 10.1016/0006-3223(96)00102-3.

2

LDL cholesterol estimation using the Anandaraja's and Friedewald's formulas in schizophrenic patients treated with antipsychotic drugs.使用阿南达拉贾公式和弗里德瓦尔德公式对接受抗精神病药物治疗的精神分裂症患者进行低密度脂蛋白胆固醇估计。

Clin Biochem. 2008 Aug;41(12):1002-7. doi: 10.1016/j.clinbiochem.2008.04.017. Epub 2008 Apr 27.

3

The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.氯氮平对精神分裂症患者血清总胆固醇及相关脂质水平的影响：一项前瞻性研究。

J Psychiatry Neurosci. 1999 Nov;24(5):453-5.

4

The lipid profiles in Japanese patients with schizophrenia treated with antipsychotic agents.日本精神分裂症患者在抗精神病药物治疗下的脂质谱。

Gen Hosp Psychiatry. 2012 Sep-Oct;34(5):525-8. doi: 10.1016/j.genhosppsych.2012.04.002. Epub 2012 May 14.

5

Nifedipine in neuroleptic-refractory schizophrenia.硝苯地平治疗抗精神病药物难治性精神分裂症

J Clin Psychopharmacol. 1987 Jun;7(3):195-6.

6

A preliminary investigation of alpha-lipoic acid treatment of antipsychotic drug-induced weight gain in patients with schizophrenia.α-硫辛酸治疗精神分裂症患者抗精神病药物所致体重增加的初步研究。

J Clin Psychopharmacol. 2008 Apr;28(2):138-46. doi: 10.1097/JCP.0b013e31816777f7.

7

Glucose and lipid metabolism of long-term risperidone monotherapy in patients with schizophrenia.精神分裂症患者长期单一使用利培酮治疗的糖脂代谢情况

Psychiatry Clin Neurosci. 2007 Feb;61(1):54-8. doi: 10.1111/j.1440-1819.2007.01610.x.

8

Metabolic profiling identifies TC and LDL as potential serum biomarkers for depressive symptoms in schizophrenia.代谢组学分析鉴定出 TC 和 LDL 可作为精神分裂症患者抑郁症状的潜在血清生物标志物。

Psychiatry Res. 2019 Nov;281:112522. doi: 10.1016/j.psychres.2019.112522. Epub 2019 Aug 17.

9

Effects of phenothiazine drugs on serum levels of apolipoproteins and lipoproteins in schizophrenic subjects.

Acta Pharmacol Sin. 2003 Oct;24(10):1001-5.

10

Management of treatment refractory schizophrenia.难治性精神分裂症的管理

Br J Psychiatry Suppl. 1996 Dec(31):15-20.

引用本文的文献

1

Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment.在长期使用氯氮平治疗期间，血清脂质的变化（与体重无关）与症状变化相关。

J Psychiatry Neurosci. 2007 Sep;32(5):331-8.

2

The neurobiology of apolipoproteins in psychiatric disorders.精神疾病中载脂蛋白的神经生物学

Mol Neurobiol. 2002 Oct-Dec;26(2-3):369-88. doi: 10.1385/mn:26:2-3:369.

3

The effects of clozapine on levels of total cholesterol and related lipids in serum of patients with schizophrenia: a prospective study.氯氮平对精神分裂症患者血清总胆固醇及相关脂质水平的影响：一项前瞻性研究。

J Psychiatry Neurosci. 1999 Nov;24(5):453-5.